10 years ahead in neurodegenerative disease with BrainDTech
24 February 2020
/
The startup BrainDTech can identify biomarkers for neurodegenerative diseases (e.g., Alzheimer’s and Parkinson’s) years before symptoms appear.
Founded in 2016, BrainDTech is an innovative startup within the Bio4Dreams network that has developed a cutting-edge approach to identifying biomarkers for neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, years before the appearance of any symptoms.
Anticipating the onset of symptoms
Currently, the diagnosis of neurological and neurodegenerative diseases (such as Alzheimer’s and Parkinson’s) is made by observing clinical symptoms.
However, these symptoms manifest when the diseases are already well-established, and the available treatments only aim to contain the symptoms and progression of the disease.
Early diagnosis
It is now scientifically established that to adequately address neurological and neurodegenerative diseases, it is crucial to act before their onset and initiate diagnostic and therapeutic pathways promptly, even before the clinical symptoms manifest.
In this context, BrainDTech has developed an innovative approach that detects the presence of biomarkers in microvesicles released by cells of the nervous system (particularly by microglia) following neuroinflammation. Their specificity allows for distinguishing between different neurodegenerative diseases.
This approach is also useful for classifying patients according to the stages of the disease, as well as for monitoring the effectiveness of a treatment.
The earlier, the better.
Fabio Bianco, CEO BrainDTech
Updates
July 2024
🏆 BrainDTech is among the 11 entities that presented the best innovative ideas in the Call4Ideas FVG: a call from the Autonomous Region of Friuli Venezia Giulia, promoted by the Cluster Scienze della Vita FVG, which awarded the selected entities privileged access to the upcoming Line B funding, thus encouraging their transformation into research and development projects. Read the news
June 2024
🚀 From June 10 to 14, BrainDTech was in San Francisco for the traction phase of CALL4INNOVIT: a program organized by INNOVIT to provide Italian companies with the skills and opportunities needed to expand and compete internationally. Read the news
September 2021
📈 BrainDTech officially becomes an innovative SME.
📗 Learn more about BrainDTech and about other entities in our portfolio.
Last updates
19 Dec 25
NERD project funded to advance training in precision oncology medicine
Led by Bio4Dreams and funded under the Interreg Italy–Switzerland Programme, NERD will train professionals to boost competitiveness in precision oncology.
19 Dec 25
ChemiCare raises €2.5M to accelerate the development of CIC-39
ChemiCare closes a €2.5M seed round with CDP Venture Capital, Bio4Dreams and Bridge4Pharma to advance CIC-39 toward the clinic.
16 Dec 25
Bio4Dreams invests in StealthMode Finance
A strategic investment in a startup specialized in fundraising, strengthening support for companies within our ecosystem.